Bacteria

Brucellosis – How Dangerous is It?

Author Stephen A. Berger, MD , 19-Sep-2020

Table of contents

Zoonotic diseases seem to be keeping the world on its toes. What is the disease responsible for the latest outbreak in China, and what is its pathogenic potential?

Not the Next COVID-19

Brucellosis is a category B bioterror disease, as classed by CDC. While it is one of the most important zoonotic diseases worldwide, brucellosis has limited pandemic potential since human-to-human transmission is sporadic and occurs via blood, sexual exposure, or breastfeeding. 

63% of cross-border events since 1965 were directly linked to the consumption of unpasteurized dairy products. The largest ever reported outbreak took place in the province of Ghardaia, Algeria, in 2016. During that time, 819 cases were recorded – health authorities suspected consumption of raw milk and famous traditional cheese, “Kamaria” may have been to blame. Epizootics (outbreaks among animals) can be much more significant.  Over 40,000 cattle acquired the disease during an outbreak in Spain in 2010. 

 

What are the Symptoms of Brucellosis?

Initial symptoms include fever, sweats, and muscle and joint pain; protracted infections may involve the heart valves, liver, or testicles.

Occupational Hazard

The outbreak in China occurred among biopharmaceutical plant workers, and several prior disease clusters have involved workers in hospital laboratories.  For this reason, individuals working with Brucella must be especially careful when handling this pathogen.

For instance, in 2007, a biodefence laboratory in the United States was closed after workers were exposed to two bioterror agents: Brucella (agent of Brucellosis) and Coxiella burnetii (agent of Q fever).  Fortunately, this incident did not result in an actual outbreak. Professionals working in such environments are well-prepared for the possibility of similar scenarios and will likely behave to minimize any risks to public health. 

Interested in learning more? Check out our ebook Brucellosis: Global Status for the latest epidemiological data, clinical findings, and potential use in bioterrorism. The ebook includes 175 graphs and 1,977 references. 

The GIDEON Difference

GIDEON is one of the most well-known and comprehensive global databases for infectious diseases. Data is refreshed daily, and the GIDEON API allows medical professionals and researchers access to a continuous data stream. Whether your research involves quantifying data, learning about specific microbes, or testing out differential diagnosis tools– GIDEON has you covered with a program that has met standards for accessibility excellence. You can also review our eBooks on AlkhurmaBotulismCryptococcus, and more. Or check out our global status updates on countries like AlgeriaCanadaIceland, and more!
Author
Stephen A. Berger, MD

Stephen A. Berger, M.D. is affiliated with the Tel Aviv Medical Center, where he has served as Director of both Geographic Medicine and Clinical Microbiology. He also holds an appointment as Emeritus Associate Professor of Medicine at the University of Tel-Aviv School of Medicine. Dr. Berger co-founded GIDEON Informatics, developers of the GIDEON (Global Infectious Diseases and Epidemiology Online Network) web app, and the GIDEON series of ebooks.

Articles you won’t delete.
Delivered to your inbox weekly.